Patents by Inventor Teresa H. Chan

Teresa H. Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4791067
    Abstract: An assay method and kit for a hapten such as theophylline employs a first, latex reagent and a second, antibody reagent. By using a monoclonal antibody of the IgA class in the second reagent, interference by patient rheumatoid factor is prevented.
    Type: Grant
    Filed: June 25, 1987
    Date of Patent: December 13, 1988
    Assignee: Fisher Scientific Co.
    Inventors: Mark I. Sheiman, Kwok K. Yeung, Teresa H. Chan
  • Patent number: 4731326
    Abstract: Methods are provided for the detection of proximal convoluted tubule causing diseases or kidney harmful drug monitoring by detecting the presence of shed normal proximal tubule associated antigens in a body fluid such as urine. The preferred embodiment employs an ELISA sandwich format wherein one monoclonal antibody specific for a first epitopic site on said antigen is immobilized on a solid phase and a second antibody, specific for a second epitopic site on said antigen is directly or indirectly labeled.
    Type: Grant
    Filed: June 4, 1984
    Date of Patent: March 15, 1988
    Assignee: Ortho Diagnostic Systems Inc.
    Inventors: Russell E. Thompson, Robert H. Rubin, Nina T. Rubin, Teresa H. Chan
  • Patent number: 4311690
    Abstract: Disclosed is a process for determining the concentration of unbound hormone, e.g., thyroxine, cortisol, or testosterone, in a liquid sample containing hormone and protein capable of binding the hormone. The sample is incubated with antibody specific to the hormone to be detected and a distinguishable analogue of the hormone, both of which are separated from the sample by semipermeable membranes capable of excluding the passage of natural protein and antibody but which allow passage of the hormone and its analogue. Preferably, the antibody and analogue are contained in semipermeable microcapsules. Free hormone in the sample permeates the membranes and competes for sites of attachment to the antibody with the analogue. The antibody and free hormones are then separated. The amount of analogue present either in association with the antibody or in the remainder of the reaction system is indicative of the level of free hormone originally present in the sample.
    Type: Grant
    Filed: June 14, 1979
    Date of Patent: January 19, 1982
    Assignee: Damon Corporation
    Inventors: Robert J. Buehler, Teresa H. Chan, Franklin Lim